tiprankstipranks
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Holding DE:4XC1?
Track your performance easily

KalVista Pharmaceuticals (4XC1) Cash flow

0 Followers

KalVista Pharmaceuticals Cash Flow

DE:4XC1's free cash flow for Q1 2025 was $-40.24M. For the 2025 fiscal year, DE:4XC1's free cash flow was decreased by $-12.82M and operating cash flow was $-40.22M. See a summary of the company’s cash flow.
Cash Flow
TTM
Apr 24Apr 23Apr 22Apr 21Apr 20
Operating Cash Flow
$ -102.72M$ -89.23M$ -75.26M$ -78.13M$ -30.17M$ -44.82M
Investing Cash Flow
$ -67.17M$ -84.72M$ 41.41M$ 57.86M$ -147.65M$ 16.75M
Financing Cash Flow
$ 153.51M$ 150.71M$ 58.12M$ 1.58M$ 212.12M$ 11.58M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 146.99M$ 31.79M$ 56.24M$ 30.73M$ 50.59M$ 15.79M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 100.39M$ 97.59M$ 57.03M$ 1.58M$ 212.12M$ 11.64M
Issuance Of Debt
-----$ -54.00K
Repayment Of Debt
-----$ -54.00K
Free Cash Flow
$ -103.07M$ -89.27M$ -76.46M$ -79.06M$ -30.25M$ -45.04M
Domestic Sales
------
Foreign Sales
------
Currency in USD

KalVista Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis